CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Celltrion Pharm Incorporated Company Snapshot
Celltrion Pharm Incorporated operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion Pharm Incorporated with three other companies in this sector in South Korea: Dae Han New Pharm Co., Ltd. (2016 sales of 109.40 billion Korean Won [US$97.26 million] ), Theragen Etex Co Limited (101.28 billion Korean Won [US$90.04 million] ), and Hyundai Pharmaceutical Company Limited (120.02 billion Korean Won [US$106.70 million] of which 86% was Pharmaceutical).

Sales Analysis. Celltrion Pharm Incorporated reported sales of 104.81 billion Korean Won (US$93.18 million) for the year ending December of 2016. This represents an increase of 40.2% versus 2015, when the company's sales were 74.73 billion Korean Won. Sales at Celltrion Pharm Incorporated have increased during each of the previous five years (and since 2011, sales have increased a total of 125%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Celltrion Pharm Incorporated
  Stock Performance Chart for Celltrion Pharm Incorporated
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 21,050
(Figures in Korean Won)
1 Week -3.7%   13 Weeks -0.5%  
4 Weeks 3.4%   52 Weeks -3.3%  
 
Celltrion Pharm Incorporated Key Data:
  Ticker: 068760 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 104,811,184,059
(Year Ending Jan 2017).
Employees: 419
  Currency: Korean Won Market Cap: 699,524,885,300
  Fiscal Yr Ends: December Shares Outstanding: 33,231,586
  Share Type: Common Closely Held Shares: 18,590,879
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.